These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33386326)

  • 21. Understanding the needs of local youth to inform drug and alcohol prevention and harm reduction services: A qualitative study.
    Deans E; Ravulo J; Blignault I; Conroy E
    Health Promot J Austr; 2021 Jul; 32(3):416-424. PubMed ID: 32745345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use and recovery: charting a course toward optimism. Interview by Kathleen R Delaney.
    Snow D
    Arch Psychiatr Nurs; 2006 Dec; 20(6):288-90. PubMed ID: 17145457
    [No Abstract]   [Full Text] [Related]  

  • 24. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
    Bonny-Noach H
    Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.
    Rosenberg H; Phillips KT
    Psychol Addict Behav; 2003 Sep; 17(3):203-10. PubMed ID: 14498814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm reduction: a new perspective on substance abuse services.
    MacMaster SA
    Soc Work; 2004 Jul; 49(3):356-63. PubMed ID: 15281690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs.
    Goldman JE; Krieger MS; Buxton JA; Lysyshyn M; Sherman SG; Green TC; Bernstein E; Hadland SE; Marshall BDL
    Subst Abus; 2019; 40(4):519-526. PubMed ID: 31206354
    [No Abstract]   [Full Text] [Related]  

  • 31. State of the art in harm reduction psychotherapy: an emerging treatment for substance misuse.
    Tatarsky A; Marlatt GA
    J Clin Psychol; 2010 Feb; 66(2):117-22. PubMed ID: 20049922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provider views of harm reduction versus abstinence policies within homeless services for dually diagnosed adults.
    Henwood BF; Padgett DK; Tiderington E
    J Behav Health Serv Res; 2014 Jan; 41(1):80-9. PubMed ID: 23404076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It'll Never Be Safe, But You Can Limit the Harms". Exploring Adolescents' Strategies to Reduce Harms Associated with Psychoactive Substance Use.
    Jakub G; Krzysztof O; Katarzyna D; Łukasz W
    Subst Use Misuse; 2022; 57(3):380-391. PubMed ID: 34895030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Health Needs and Priorities of People Who Access Comprehensive Harm Reduction Programs.
    Chhabra M; Stavas N; Vij N; Kumar E; Shea JA
    J Health Care Poor Underserved; 2020; 31(4):1747-1764. PubMed ID: 33416750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Still "at risk": An examination of how street-involved young people understand, experience, and engage with "harm reduction" in Vancouver's inner city.
    Bozinoff N; Small W; Long C; DeBeck K; Fast D
    Int J Drug Policy; 2017 Jul; 45():33-39. PubMed ID: 28578217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating mobile harm reduction services for youth and young adults.
    Yeo EJ; Hausman E; Noyes E; Chatterjee A
    Front Public Health; 2024; 12():1375323. PubMed ID: 38841665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.